We are live on ! Find out more
IBIO icon

iBio
IBIO

16 hedge funds and large institutions have $1.01M invested in iBio in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

6% less funds holding

Funds holding: 17 → 16 (-1)

13% less capital invested

Capital invested by funds: $1.16M → $1.01M (-$151K)

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$37.1K
2
TSS
Two Sigma Securities
New York
+$29K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$16.1K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.22K
5
BlackRock
BlackRock
New York
+$1.61K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$22K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$11.3K

IBIO Hedge Fund Activity: Q3 2017 in Review

16 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2017, worth a combined $1.01M — down 13% from $1.16M a quarter earlier.

Fund positioning in IBIO was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $37.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $22K sold.

  • 16 institutional investors held iBio (IBIO) as of Q3 2017, down from 17 in Q2 2017.
  • Funds reported $1.01M of iBio stock for Q3 2017, down 13% quarter-over-quarter.
  • 1 fund opened new iBio positions in Q3 2017 and 1 closed out, a net change of 0 holders.
  • The largest iBio buyer in Q3 2017 was Virtu Financial, an estimated $37.1K added.
  • The largest iBio seller in Q3 2017 was Citadel Advisors, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2017.